es can collect some =oundational CRISPR IP, Editas has derisked concerns around its freedom =o operate. The USPTO issued final judgment in favor of the Broad Institute/Editas =n the interference proceedings between the Broad Institute and the =niversity of California. The Broad Institute holds the patents =urrounding the